How many boxes of Ponatinib should you take a month?

Ponatinib's side effects during the treatment of chronic myelogenous leukemia (CML) are very similar to those of other tyrosine kinase inhibitors and can mostly be controlled by reducing or delaying the dose. By checking for and treating causative factors such as high blood pressure and elevated cholesterol before and during treatment, you can reduce your risk of problems caused by blood clots or blockages in your arteries or veins, including heart attacks and strokes.

Ponatinib is available in tablets (15mg, 30mg and 45mg). The recommended starting dose is 45 mg once daily. Treatment continues as long as the patient does not experience side effects or continues to benefit from the drug. The common specification of ponatinib is 45mg*30 tablets per box, so patients may need to take about 1 box per month. If a patient experiences certain serious side effects, the doctor may decide to reduce subsequent doses or delay or stop treatment. If white blood cell levels in the blood do not return to normal within three months, doctors should consider stopping treatment, at which point the patient's monthly dose will be adjusted.

The original drug of Ponatinib has not yet been launched in China, so it is not included in the medical insurance. Domestic patients in need may only purchase it through overseas channels. The Hong Kong original version of Ponatinib specificationsThe price of 45mg*30 tablets per box may be around 40,000 yuan (the price may fluctuate due to the exchange rate), which is expensive. There are also generic ponatinib drugs produced in other countries, which are relatively cheap. The price of 45mg*30 tablets per box produced by Everest Pharmaceutical Factory in Bangladesh may be around 4,000 yuan (the price may fluctuate due to the exchange rate), and its drug ingredients are basically the same as those of the original drug.